NM_001378452.1(ITPR1):c.4288A>G (p.Ile1430Val) AND not provided

Germline classification:: Benign/Likely benign (2 submissions)
Last evaluated:: Jan 30, 2024
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000884285.10

Allele description [Variation Report for NM_001378452.1(ITPR1):c.4288A>G (p.Ile1430Val)]

NM_001378452.1(ITPR1):c.4288A>G (p.Ile1430Val)

Gene:

ITPR1:inositol 1,4,5-trisphosphate receptor type 1 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

3p26.1

Genomic location:

Preferred name:

NM_001378452.1(ITPR1):c.4288A>G (p.Ile1430Val)

HGVS:

NC_000003.12:g.4697153A>G
NG_016144.1:g.208806A>G
NM_001099952.4:c.4261A>G
NM_001168272.2:c.4243A>G
NM_001378452.1:c.4288A>GMANE SELECT
NM_002222.7:c.4216A>G
NP_001093422.2:p.Ile1421Val
NP_001161744.1:p.Ile1415Val
NP_001161744.1:p.Ile1415Val
NP_001365381.1:p.Ile1430Val
NP_002213.5:p.Ile1406Val
NC_000003.11:g.4738837A>G
NM_001168272.1:c.4243A>G
NM_002222.5:c.4216A>G
NM_002222.6:c.4216A>G

Protein change:

I1406V

Links:

dbSNP: rs3749383

NCBI 1000 Genomes Browser:

rs3749383

Molecular consequence:

NM_001099952.4:c.4261A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001168272.2:c.4243A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001378452.1:c.4288A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_002222.7:c.4216A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

SAMN24048644 (1)
SRA
Diaporthe eres isolate JZB320290 beta-tubulin (TUB) gene, partial cds
Diaporthe eres isolate JZB320290 beta-tubulin (TUB) gene, partial cds
gi|2798388448|gb|PQ093774.1|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001027652	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Benign (Jan 30, 2024)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]
SCV001773044	GeneDx	criteria provided, single submitter (GeneDx Variant Classification Process June 2021)	Likely benign (Oct 22, 2020)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001027652

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Benign
(Jan 30, 2024)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001773044

GeneDx

criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)

Likely benign
(Oct 22, 2020)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	not provided	not provided	not provided	not provided	not provided	clinical testing
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001027652.5

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From GeneDx, SCV001773044.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine